These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12620947)

  • 21. Compound A production from sevoflurane is not less when KOH-free absorbent is used in a closed-circuit lung model system.
    Versichelen L; Bouche MP; Struys M; Van Bocxlaer J; Mortier E; de Leenheer AP; Rolly G
    Br J Anaesth; 2001 Mar; 86(3):345-8. PubMed ID: 11573522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The compound A concentration in a low-flow anesthesia circuit using the new CO2 absorbent SPHERASORB].
    Obata R; Bito H; Katoh T; Sato S
    Masui; 2000 May; 49(5):504-8. PubMed ID: 10846381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partly exhausted soda lime or soda lime with water added, inhibits the increase in compound A concentration in the circle system during low-flow sevoflurane anaesthesia.
    Moriwaki G; Bito H; Ikeda K
    Br J Anaesth; 1997 Dec; 79(6):782-6. PubMed ID: 9496213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
    Eger EI; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia].
    Förster H; Behne M; Warnken UH; Asskali F; Dudziak R
    Anaesthesist; 2000 Feb; 49(2):106-12. PubMed ID: 10756964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal toxicity with sevoflurane: a storm in a teacup?
    Gentz BA; Malan TP
    Drugs; 2001; 61(15):2155-62. PubMed ID: 11772127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification in rat bile of glutathione conjugates of fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether, a nephrotoxic degradate of the anesthetic agent sevoflurane.
    Jin L; Davis MR; Kharasch ED; Doss GA; Baillie TA
    Chem Res Toxicol; 1996 Mar; 9(2):555-61. PubMed ID: 8839062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
    Sheffels P; Schroeder JL; Altuntas TG; Liggitt HD; Kharasch ED
    Chem Res Toxicol; 2004 Sep; 17(9):1177-89. PubMed ID: 15377151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide.
    Stabernack CR; Brown R; Laster MJ; Dudziak R; Eger EI
    Anesth Analg; 2000 Jun; 90(6):1428-35. PubMed ID: 10825335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Compound A: toxicology and clinical relevance].
    Kharasch ED
    Anaesthesist; 1998 Nov; 47 Suppl 1():S7-10. PubMed ID: 9893874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No compound a formation with Superia during minimal-flow sevoflurane anesthesia: a comparison with Sofnolime.
    Bouche MP; Versichelen LF; Struys MM; Van Bocxlaer JF; De Leenheer AP; Mortier EP; Rolly G
    Anesth Analg; 2002 Dec; 95(6):1680-5, table of contents. PubMed ID: 12456439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiorespiratory effects of low-flow and closed circuit inhalation anesthesia, using sevoflurane delivered with an in-circuit vaporizer and concentrations of compound A.
    Muir WW; Gadawski J
    Am J Vet Res; 1998 May; 59(5):603-8. PubMed ID: 9582964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans.
    Mchaourab A; Arain SR; Ebert TJ
    Anesthesiology; 2001 Jun; 94(6):1007-9. PubMed ID: 11465591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime.
    Fang ZX; Kandel L; Laster MJ; Ionescu P; Eger EI
    Anesth Analg; 1996 Apr; 82(4):775-81. PubMed ID: 8615497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compound A concentrations during sevoflurane anesthesia in children.
    Frink EJ; Green WB; Brown EA; Malcomson M; Hammond LC; Valencia FG; Brown BR
    Anesthesiology; 1996 Mar; 84(3):566-71. PubMed ID: 8659785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione S-conjugation of the sevoflurane degradation product, fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in human liver, kidney, and blood in vitro.
    Altuntas TG; Kharasch ED
    Toxicol Appl Pharmacol; 2001 Dec; 177(2):85-93. PubMed ID: 11740907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Differential reactivities of three kinds of carbon dioxide absorbents with high concentration of sevoflurane].
    Nakazawa M; Miyano K; Toriumi K; Tanifuzi Y
    Masui; 1994 Aug; 43(8):1216-20. PubMed ID: 7933505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Compound A: does it matter?
    Eger EI
    Can J Anaesth; 2001 May; 48(5):427-30. PubMed ID: 11394507
    [No Abstract]   [Full Text] [Related]  

  • 40. [Low alkali-hydroxide content in soda limes does not lead to reduction of compound A formation from sevoflurane during low-flow anesthesia].
    Reichle FM; Conzen P; Czerner S; Gröger G; Peter K
    Anaesthesist; 2001 Mar; 50(3):155-61. PubMed ID: 11315487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.